18.11.2020 20:35:00
|
Clinical Chemistry Analyzer Has Utility in Multiple Laboratory Settings and During COVID-19 Crisis with its Small Size and Vast Menu
GREENSBORO, N.C., Nov. 18, 2020 /PRNewswire/ -- The Medica EasyRA® benchtop clinical chemistry analyzer, distributed and serviced by Greensboro-based company, Carolina Liquid Chemistries Corp. (CLC), allows healthcare providers to test routine blood chemistries to include metabolic panels, liver enzymes, kidney function tests, glucose and cardiovascular tests. These tests are especially useful at a time when it is critical to check the overall health of COVID-19 patients.
Medica EasyRA®'s tests are very useful at a time when it is critical to check the overall health of COVID-19 patients.The analyzer can also be used to screen for drugs of abuse or pain management medication. Its extensive menu is excellent for a family practice, urgent care, oncology, and other specialty practices with laboratories.
The EasyRA® clinical chemistry analyzer fits into multiple settings where fast, actionable outcomes are required to diagnose and track the progression of a variety of diseases and interventions. The EasyRA®'s small size and ease of operation make it well equipped for space-restricted locations such as mobile test centers, urgent care centers, COVID-19 hospital floors, physician office laboratories, or reference laboratories and hospitals with satellite locations.
The EasyRA® clinical chemistry analyzer also offers photometric throughput of up to 240 tests per hour or up to 480 tests per hour with electrolytes. Technicians can analyze STAT samples in less than 8 minutes.
About Carolina Liquid Chemistries Corp.
Headquartered in Greensboro, NC, Carolina Liquid Chemistries Corp. (CLC) is an authorized manufacturer, re-packager, re-labeler and value-added distributor of chemistry systems and reagents, as well as COVID-19 testing supplies. CLC helps clinical laboratories of all sizes reduce chemistry analyzer and reagent costs, while also receiving accurate and timely results. The company has responded to the COVID-19 pandemic by bringing several PCR and antibody tests to market under the FDA's Emergency Use Authorization. For more information, visit carolinachemistries.com or email contactsales@carolinachemistries.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/clinical-chemistry-analyzer-has-utility-in-multiple-laboratory-settings-and-during-covid-19-crisis-with-its-small-size-and-vast-menu-301176369.html
SOURCE Carolina Liquid Chemistries
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!